Metraipolis › archive › dc_15ae88bb7819
Severe systemic cutaneous adverse reactions following camrelizumab therapy: a case report and literature review — Europe PMC PMID:41488619
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41488619
- DOI
- 10.3389/fimmu.2025.1714201
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T12:57:47.097Z
- SHA-256 of the archived text
0afd4560d6ed4c283ca04466b7f97f0f3a15a72f904143ea85551ef2c70adc19- Stable URL of this page
https://metraipolis.com/documento/dc_15ae88bb7819
How to cite
Severe systemic cutaneous adverse reactions following camrelizumab therapy: a case report and literature review — Europe PMC PMID:41488619 — Europe PMC (en), https://europepmc.org/article/MED/41488619 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_15ae88bb7819 (Metraipolis archive dc_15ae88bb7819, sha256 0afd4560d6ed4c283ca04466b7f97f0f3a15a72f904143ea85551ef2c70adc19)
BibTeX
@misc{dc15ae88bb7819,
title = {Severe systemic cutaneous adverse reactions following camrelizumab therapy: a case report and literature review — Europe PMC PMID:41488619},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41488619},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_15ae88bb7819; sha256 0afd4560d6ed4c283ca04466b7f97f0f3a15a72f904143ea85551ef2c70adc19},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488619. Agents can read the archived copy with the MCP tool read_document.